Source - RNS
RNS Number : 5308X
Santander UK Group Holdings PLC
10 August 2018


The following supplementary prospectus (the Supplementary Prospectus) has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 10 August 2018 to the base prospectus dated 30 August 2017, as supplemented previously on 14 September 2017, 26 October 2017, 7 February 2018, 1 March 2018, 24 April 2018, 25 June 2018 and 25 July 2018 relating to the €30,000,000,000 Euro Medium Term Note Programme of Santander UK Group Holdings plc and Santander UK plc (the Base Prospectus).

To view the full Supplementary Prospectus please paste the following URL into the address bar of your browser:

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at:

The Supplementary Prospectus will also be available for viewing via:

For further information, please contact:

Medium Term Funding
Santander UK plc
2 Triton Square
Regent's Place
London NW1 3AN

Tel: +44 (0) 20 7756 7100

Email: [email protected]


Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Base Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from such Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

This publication of the Supplementary Prospectus does not constitute an offer of securities for sale in the United States. The securities described in any Base Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Your right to access this service is conditional upon your compliance with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit